T. Rowe Price Investment Management
SHC icon

T. Rowe Price Investment Management’s Sotera Health SHC Stock Holding History

T. Rowe Price Investment Management’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187M Buy
10,518,373
+1,392,752
+15% +$22M 0.12% 191
2026
Q1 		$131M Buy
9,125,621
+260,825
+3% +$4.33M 0.09% 214
2025
Q4 		$156M Sell
8,864,796
-354,197
-4% -$5.86M 0.1% 191
2025
Q3 		$145M Buy
9,218,993
+165,528
+2% +$2.32M 0.09% 221
2025
Q2 		$101M Buy
9,053,465
+1,007,963
+13% +$11.8M 0.06% 278
2025
Q1 		$93.8M Buy
8,045,502
+450,761
+6% +$5.8M 0.06% 290
2024
Q4 		$104M Sell
7,594,741
-1,823,250
-19% -$26.4M 0.06% 288
2024
Q3 		$157M Buy
9,417,991
+3,330,278
+55% +$48.6M 0.09% 219
2024
Q2 		$72.3M Buy
6,087,713
+1,050,848
+21% +$12M 0.05% 330
2024
Q1 		$60.5M Buy
5,036,865
+1,444,834
+40% +$21.5M 0.04% 362
2023
Q4 		$60.5M Buy
3,592,031
+331,327
+10% +$4.69M 0.04% 365
2023
Q3 		$48.8M Buy
3,260,704
+2,694,747
+476% +$45.5M 0.03% 366
2023
Q2 		$10.7M Buy
+565,957
New +$8.99M 0.01% 513

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management's SHC Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Sotera Health (SHC) stake by 15% in Q2 2026, buying an estimated $22M and bringing the position to 10,518,373 shares worth $187M. The position accounts for 0.12% of the portfolio, ranked #191.

T. Rowe Price Investment Management first reported a position in SHC in Q2 2023 and has held it in 13 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • T. Rowe Price Investment Management held 10,518,373 shares of Sotera Health worth $187M as of Q2 2026.
  • T. Rowe Price Investment Management bought 1,392,752 Sotera Health shares in Q2 2026, an estimated $22M.
  • Sotera Health made up 0.12% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #191 holding.
  • T. Rowe Price Investment Management first reported a position in Sotera Health in Q2 2023 and has held it in 13 quarters since.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.